SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-009519
Filing Date
2022-04-11
Accepted
2022-04-08 21:14:48
Documents
114
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1977167
2 ex4-1.htm EX-4.1 20523
3 ex31-1.htm EX-31.1 12082
4 ex31-2.htm EX-31.2 10417
5 ex32-1.htm EX-32.1 8600
6 ex32-2.htm EX-32.2 8189
7 form10-k_001.jpg GRAPHIC 6597
8 form10-k_002.jpg GRAPHIC 6177
9 GRAPHIC image_001.jpg GRAPHIC 10552
  Complete submission text file 0001493152-22-009519.txt   8304910

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE bfri-20211231.xsd EX-101.SCH 75963
11 XBRL CALCULATION FILE bfri-20211231_cal.xml EX-101.CAL 82424
12 XBRL DEFINITION FILE bfri-20211231_def.xml EX-101.DEF 311368
13 XBRL LABEL FILE bfri-20211231_lab.xml EX-101.LAB 539518
14 XBRL PRESENTATION FILE bfri-20211231_pre.xml EX-101.PRE 440843
108 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1006101
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40943 | Film No.: 22818330
SIC: 2834 Pharmaceutical Preparations